Haverford Financial Services Inc. cut its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.1% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 53,197 shares of the healthcare conglomerate’s stock after selling 67 shares during the period. UnitedHealth Group comprises approximately 5.5% of Haverford Financial Services Inc.’s holdings, making the stock its 2nd largest position. Haverford Financial Services Inc.’s holdings in UnitedHealth Group were worth $13,252,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Oregon Public Employees Retirement Fund grew its position in UnitedHealth Group by 50,446.5% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 53,349,795 shares of the healthcare conglomerate’s stock worth $214,000 after acquiring an additional 53,244,249 shares in the last quarter. Capital International Investors grew its position in UnitedHealth Group by 223.0% in the third quarter. Capital International Investors now owns 16,319,843 shares of the healthcare conglomerate’s stock worth $4,341,731,000 after acquiring an additional 11,267,910 shares in the last quarter. BlackRock Inc. grew its position in UnitedHealth Group by 3.1% in the fourth quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock worth $17,396,391,000 after acquiring an additional 2,123,417 shares in the last quarter. Rehmann Capital Advisory Group grew its position in UnitedHealth Group by 26,088.2% in the third quarter. Rehmann Capital Advisory Group now owns 1,723,185 shares of the healthcare conglomerate’s stock worth $6,477,000 after acquiring an additional 1,716,605 shares in the last quarter. Finally, Vanguard Group Inc grew its position in UnitedHealth Group by 1.6% in the third quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after acquiring an additional 1,073,505 shares in the last quarter. 86.68% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts have commented on UNH shares. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, December 18th. Oppenheimer boosted their target price on shares of UnitedHealth Group from $300.00 to $305.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 16th. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research report on Friday, January 11th. Argus boosted their target price on shares of UnitedHealth Group from $285.00 to $295.00 and gave the stock a “buy” rating in a research report on Monday, December 17th. Finally, Credit Suisse Group reissued a “buy” rating and issued a $310.00 target price on shares of UnitedHealth Group in a research report on Friday, February 8th. Three research analysts have rated the stock with a hold rating and twenty have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $297.80.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Tuesday, January 22nd. The shares were sold at an average price of $266.61, for a total transaction of $1,333,050.00. Following the completion of the transaction, the director now directly owns 77,702 shares in the company, valued at approximately $20,716,130.22. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Gail R. Wilensky sold 2,930 shares of the company’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $253.39, for a total transaction of $742,432.70. Following the transaction, the director now owns 64,726 shares of the company’s stock, valued at $16,400,921.14. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,930 shares of company stock valued at $8,495,383. Corporate insiders own 0.87% of the company’s stock.

NYSE UNH opened at $246.03 on Thursday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.64. The firm has a market cap of $238.72 billion, a P/E ratio of 19.10, a PEG ratio of 1.27 and a beta of 0.79. UnitedHealth Group Inc has a 1 year low of $221.69 and a 1 year high of $287.94.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.20 by $0.08. The business had revenue of $58.42 billion during the quarter, compared to the consensus estimate of $58.01 billion. UnitedHealth Group had a net margin of 5.30% and a return on equity of 24.38%. UnitedHealth Group’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.59 EPS. On average, equities research analysts expect that UnitedHealth Group Inc will post 14.62 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 1.46%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 27.95%.

ILLEGAL ACTIVITY WARNING: This story was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.watchlistnews.com/unitedhealth-group-inc-unh-position-reduced-by-haverford-financial-services-inc/2954554.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Why are trading ranges significant?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.